Dalekos G et al. Efficacy of GKT831 in patients with primary biliary cholangitis and inadequate response to ursodeoxycholic acid: Interim efficacy results of a phase 2 clinical trial. (Abstract GS-02)
Toevoeging imuuncellen aan organoïden opent deuren voor virusonderzoek
jun 2025 | Virale infecties